share_log

Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $71

Benzinga ·  Jul 15 13:02

Morgan Stanley analyst Drew Ranieri maintains Globus Medical (NYSE:GMED) with a Equal-Weight and raises the price target from $67 to $71.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment